BRONCHIOLITIS OBLITERANS
Clinical trials for BRONCHIOLITIS OBLITERANS explained in plain language.
Never miss a new study
Get alerted when new BRONCHIOLITIS OBLITERANS trials appear
Sign up with your email to follow new studies for BRONCHIOLITIS OBLITERANS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope to halt lung damage after Life-Saving transplants
Disease control Recruiting nowThis study is testing a drug called belumosudil to see if it can help control a serious lung scarring condition called bronchiolitis obliterans syndrome (BOS). BOS can develop in people who have received a donor stem cell transplant. The trial will enroll 45 adults who have eithe…
Matched conditions: BRONCHIOLITIS OBLITERANS
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Apr 03, 2026 22:41 UTC
-
Scientists search for early clues to devastating lung disease
Knowledge-focused Recruiting nowThis study aims to learn more about specific cells in the airways of people who develop a serious lung condition called bronchiolitis obliterans syndrome after a lung or stem cell transplant. Researchers will collect cell samples from 15 patients during their standard medical car…
Matched conditions: BRONCHIOLITIS OBLITERANS
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Apr 03, 2026 22:41 UTC